Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- Latest CDC Findings: A Wake‑Up Call for the $1.3 Billion Global Sepsis Diagnostics Market April 6, 2026
- NAMs, NIH Policy, and What it Means for Diagnostics March 20, 2026
- As Flu Outpaces COVID This Winter, Rapid Molecular Testing Takes on New Importance March 17, 2026
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Molecular Point of Care Test Market Nearly Triples in One Year, Due to COVID-19.
Molecular systems that can test at the point of care was always expected to be a factor in COVID-19. Last year, when our report published, the novel coronavrius was limited in most news accounts to a disease affecting Wuhan, China, we said this: “As presented, the revenues for this segment are forecast to increase from […]
COVID-19 Pandemic Accelerates Adoption of Diagnostic Testing at Point of Care
From Lab Pulse , a sister publication to Kalorama Information – www.labpulse.com Experience with COVID-19 has cast a bright light on the state of healthcare and the great need for change, which has already begun, said panelist Rahul Dhanda, co-founder and CEO of Sherlock Biosciences, a pioneer in diagnostics based on CRISPR gene editing technology. […]
Science and Medicine Groups Predictions for 2021 in the Lab Instrumentation, Diagnostics and Imaging Industries
The unpredictable events of 2020 might cause one forswear all prediction-making. Yet for Science and Medicine Group, the publishing brands we offer (Strategic Directions International, Bioinformatics, Kalorama Information, IMV, Instrument Business Outlook) are in the business of prediction-making. Thus once again, we offer our top ten predictions for 2021 based on our market research publications: Recovery in […]
For Roche, Alignment Between Tests and COVID-19 Vaccines is Key
The distribution of COVID-19 vaccines has focused testmakers on how they can continue to contribute when vaccines are released. For Roche Diagnostics, vaccines and tests and their alignment are key to 2021 growth. Roche held its session “Entitled COVID-19: The critical role of Diagnostics,” on the first day of The American Association of Clinical Chemistry, […]
Lab Industry Voices, Diagnostic Innovation, and Ugly Sweater Parties: What We’ll be Watching at #2020AACC
Although virtual this year, this years meeting of the American Association for Clinical Chemistry (AACC) is probably more important than ever. The industry is at the forefront of worldwide efforts to combat the COVID-19 disease. In the United States, national focus is on laboratorians in an unprecedented way. In vitro diagnostic vendors are under pressure […]
Urgent Care and Its Enemies
Urgent care locations have grown over the past decade, Kalorama estimates the urgent care locations in the United States to be 9,900, growing from nearly 7,000 in 2013. That’s spectacular growth, driven by a need for more healthcare services, improved insured populations and resistance to physician office waiting times. Because of these undisputable positives, it’s […]
Siemens Healthineers Announces COVID-19 Neutralizing Antibodies Test
Siemens Healthineers yesterday announced its SARS-CoV-2 IgG Antibody Test (sCOVG)1 has proven to measure neutralizing antibodies and has achieved CE Mark. The test is an enhanced version of the assay which became available globally this summer, including in the U.S. It demonstrates the ability to detect neutralizing antibodies and reports quantitative results measuring the amount […]
Vaccines Won’t Eliminate the Need for COVID-19 Testing
Surprising effectiveness levels for COVID-19 vaccine candidates have been reported in the news lately, with Pfizer and Moderna releasing company data. This rightly gives many hope, and also may lead to a question as to whether the PCR and immunoassay testing for the disease we are seeing in 2020 will continue much longer. It may […]
Vaccine Market Grows to 37.4 BN
In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015. The finding was made in Kalorama Information’s report, Vaccines 2020 (https://kaloramainformation.com/product/vaccines-2020-world-market-analysis-players-trends/). Strong continued growth in the global vaccines market is expected through 2025, specifically: Growth at high double-digit rates. Sales of adult vaccines are expected […]
Fueled by Antigen Testing, COVID-19 Testing Market Soars to 10.5 BN: Report
In its COVID-19 Update report, Kalorama Information said that volume was up in labs and among IVD vendors, new technologies are available. Kalorama projects a 10.5 billion-dollar market for COVID-19. This is a 1 billion dollar increase from previous estimates. For most aspects of the diagnostic testing process, there has still been a learning curve […]